Genocea Biosciences, Inc.

GNCACIK 0001457612 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0024

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Genocea Biosciences, Inc.

Name	Roles	Filings
Florence Anthony A. Jr.	10% Owner	1
Lunger John	Director	1
Makhzoumi Mohamad	10% Owner	1
Nea 16 Gp, LLC	10% Owner	1
Nea Partners 16, L.P.	10% Owner	1

Showing 11-15 of 20

Per pagePrevPage 3 of 4Next

All filings

31 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 26, 2022	Makhzoumi Mohamad 10% Owner	SSale	5,931,843	$0.0654	$387,943
May 26, 2022	New Enterprise Associates 16, L.P. 10% Owner	SSale	5,931,843	$0.0654	$387,943
May 26, 2022	Sandell Scott D 10% Owner	SSale	5,931,843	$0.0654	$387,943
May 26, 2022	Sonsini Peter W. 10% Owner	SSale	5,931,843	$0.0654	$387,943
May 26, 2022	Walker Paul Edward 10% Owner	SSale	5,931,843	$0.0654	$387,943

Showing 11-15 of 31

Per pagePrevPage 3 of 7Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value